Carlsmed (CARL) Gross Margin (2024 - 2026)

Carlsmed (CARL) has reported Gross Margin for 3 consecutive years, with 76.78% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Margin rose 338.0% year-over-year to 76.78%; the trailing twelve-month figure through Jun 2026 stood at 76.63% (up 261.0% YoY), and the FY2025 full-year result was 75.31%, up 151.0% from the prior year.
• Gross Margin held at 76.78% in Q2 2026 per CARL's latest filing, from 77.1% in the prior quarter.
• Across five years, Gross Margin topped out at 77.1% in Q1 2026 and bottomed at 72.81% in Q3 2024.
• Historically, Gross Margin has averaged 75.24% across 3 years, with a median of 75.02% in 2024.
• The sharpest annual moves came in 2025 and 2026: Gross Margin plunged 162 bps in 2025, then surged 338 bps in 2026.
• Over 3 years, Gross Margin stood at 74.66% in 2024, then grew by 3 bps to 76.54% in 2025, then grew by 0 bps to 76.78% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 76.78%, 77.1%, and 76.54% for Q2 2026, Q1 2026, and Q4 2025 respectively.